DOROTHY MILBURN: Open Payments
NPI 1477520690 · BRAYMER, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$479 in 24 payments from 13 companies in 2025. Trend: 2023 $593 · 2024 $870 · 2025 $479
Food & beverage: $479
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $86 |
| Lundbeck LLC | 3 | $71 |
| Novo Nordisk Inc | 3 | $53 |
| HARMONY BIOSCIENCES LLC | 2 | $51 |
| Lilly USA, LLC | 3 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Viatris Specialty LLC | 1 | $16 |
Products named: REXULTI, WAKIX, MOUNJARO, CAPLYTA, UBRELVY, Wegovy, VRAYLAR, QULIPTA.
Industry payments across MO — which companies pay providers there.
